Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 1,057-1,068 of 1,740
Drug study icon
CompletedNCT00763971

Safety study of Lisdexamfetamine Dimesylate (LDX) in ADHD

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.

Multiple locations, including Hoboken
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 17 Years
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire
Condition
ADHD
Other study type icon
CompletedNCT00181857

Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
CompletedNCT01939353

Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) for ADHD

This study is completed in the United States. It is testing Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) for ADHD.

Multiple locations, including Bradenton
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.